Laboratory Analytical Instruments - Insider Trading Data

Insiders are officers, directors, or significant investors. This page shows insider sentiment and transactions for the Laboratory industry. Research shows that insider trades are predictive of future stock returns. By examining insider trades for an industry, we can understand what well-informed people think of the overall future industry prospects.

Laboratory Analytical Instruments - Insider Buy/Sell Ratio

Insider selling and buying is a useful indicator for analyzing the market because it serves as a proxy for their optimism or pessimism in their own companies. By looking at ratio of total selling and buying across the entire market, we might be able to draw some conclusions about the future market.

We offer two charts here. The first one shows the total dollar volume of buying and selling by insiders. The second chart shows the ratio of the number of insiders selling, vs. the number of insiders buying. In both charts, we filter out trades made by indirect holders (such as trusts), and 10% owners (who, although considered an 'insider' by the SEC, do not actually manage the companies in which they are considered insiders).

Corporate Insider Buy Sell Ratio (Dollar Volume) - Laboratory Analytical Instruments
Corporate Insider Buy Sell Ratio (Insider Count) - Laboratory Analytical Instruments
Laboratory Analytical Instruments - Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Security Form Insider Code 10b5-1 Direct Share
Price
Shares
Changed
2025-02-04 QTRX / Quanterix Corporation 4 Toloue Masoud A - Award D 138,790
2025-02-04 QTRX / Quanterix Corporation 4 Sriram Vandana A - Award D 50,712
2025-02-04 RVTY / Revvity, Inc. 4 Goldberg Joel S A - Award D 4,939
2025-02-02 QTRX / Quanterix Corporation 4 Toloue Masoud F - Taxes D 9.19 -6,077
2025-02-02 QTRX / Quanterix Corporation 4 Sriram Vandana F - Taxes D 9.19 -2,166
2025-01-31 QTRX / Quanterix Corporation 4 Toloue Masoud F - Taxes D 9.19 -298
2025-01-30 RVTY / Revvity, Inc. 4 Goldberg Joel S S - Sale D 126.9 -10,660
2025-01-30 RVTY / Revvity, Inc. 4 Goldberg Joel S S - Sale D 125.99 -2,710
2025-01-30 RVTY / Revvity, Inc. 4 Goldberg Joel S S - Sale D 124.45 -500
2025-01-30 RVTY / Revvity, Inc. 4 Goldberg Joel S S - Sale D 127.77 -1,300
2025-01-30 RVTY / Revvity, Inc. 4 Goldberg Joel S M - Exercise D 81.29 15,170
2025-01-30 PACB / Pacific Biosciences of California, Inc. 4 Smith Christopher M A - Award D 54,099
2025-01-28 A / Agilent Technologies, Inc. 4 Gonsalves Rodney Gonsalves Trust G - Gift I 150.34 7,149
2025-01-28 A / Agilent Technologies, Inc. 4 Gonsalves Rodney G - Gift D 150.34 -7,149
2025-01-28 A / Agilent Technologies, Inc. 4/A Gonsalves Rodney G - Gift D 150.34 7,149
2025-01-28 A / Agilent Technologies, Inc. 4/A Gonsalves Rodney Gonsalves Trust G - Gift I 150.34 -7,149
2025-01-21 A / Agilent Technologies, Inc. 4 MCDONNELL PADRAIG S - Sale D 150.00 -1,911
2025-01-15 QTRX / Quanterix Corporation 4 Toloue Masoud F - Taxes D 8.62 -906
2025-01-15 QTRX / Quanterix Corporation 4 Sriram Vandana F - Taxes D 8.62 -93
2025-01-15 PRPO / Precipio, Inc. 4 SANDBERG RICHARD A A - Award D 6.10 2,704
2025-01-15 PRPO / Precipio, Inc. 4 Cossman Jeffrey A - Award D 6.10 1,721
2025-01-15 PRPO / Precipio, Inc. 4 ANDREWS RONALD ASBURY A - Award D 6.10 1,639
2025-01-15 PRPO / Precipio, Inc. 4 Cossman Jeffrey A - Award D 6.10 1,721
2025-01-15 PRPO / Precipio, Inc. 4 Cohen David Seth A - Award D 6.10 2,151
2025-01-10 PACB / Pacific Biosciences of California, Inc. 4 Van Oene Mark S - Sale D 2.034 -34,405
2025-01-07 RVTY / Revvity, Inc. 4 Vohra Tajinder S - Sale D 118.92 -200
2025-01-07 RVTY / Revvity, Inc. 4 Vohra Tajinder S - Sale D 116.13 -2,430
2025-01-07 RVTY / Revvity, Inc. 4 Vohra Tajinder S - Sale D 117.79 -474
2025-01-07 RVTY / Revvity, Inc. 4 Vohra Tajinder S - Sale D 117.14 -2,388
2025-01-07 RVTY / Revvity, Inc. 4 Vohra Tajinder M - Exercise D 81.29 5,492
2025-01-06 EYPT / EyePoint Pharmaceuticals, Inc. 4 Elston George M - Exercise D 15,285
2025-01-06 EYPT / EyePoint Pharmaceuticals, Inc. 4 Lurker Nancy M - Exercise D 75,134
2025-01-06 EYPT / EyePoint Pharmaceuticals, Inc. 4 Duker Jay S. M - Exercise D 20,794
2025-01-06 EYPT / EyePoint Pharmaceuticals, Inc. 4 Duker Jay S. F - Taxes D 8.68 -6,108
2025-01-06 EYPT / EyePoint Pharmaceuticals, Inc. 4 Elston George F - Taxes D 8.68 -4,808
2025-01-05 EYPT / EyePoint Pharmaceuticals, Inc. 4 Elston George M - Exercise D 15,000
2025-01-05 EYPT / EyePoint Pharmaceuticals, Inc. 4 Landis John B. M - Exercise D 10,000
2025-01-05 EYPT / EyePoint Pharmaceuticals, Inc. 4 Lurker Nancy M - Exercise D 12,667
2025-01-05 EYPT / EyePoint Pharmaceuticals, Inc. 4 Duker Jay S. M - Exercise D 30,000
2025-01-05 ILMN / Illumina, Inc. 4 Davies Scott M F - Taxes D 138.65 -1,068
2025-01-05 ILMN / Illumina, Inc. 4 Barnard Steven F - Taxes D 138.65 -1,068
2025-01-05 EYPT / EyePoint Pharmaceuticals, Inc. 4 Duker Jay S. F - Taxes D 8.26 -10,007
2025-01-05 EYPT / EyePoint Pharmaceuticals, Inc. 4 Elston George F - Taxes D 8.26 -5,267
2025-01-05 ILMN / Illumina, Inc. 4 Ericksen Scott D F - Taxes D 138.65 -1,068
2025-01-05 ILMN / Illumina, Inc. 4 Leckman Patricia F - Taxes D 138.65 -1,068
2025-01-02 WAT / Waters Corporation 4 Huang Pearl S A - Award D 319
2025-01-02 WAT / Waters Corporation 4 KUEBLER CHRISTOPHER A A - Award D 319
2025-01-02 WAT / Waters Corporation 4 Ornskov Flemming A - Award D 319
2025-01-02 WAT / Waters Corporation 4 Jiang Wei A - Award D 319
2025-01-02 QTRX / Quanterix Corporation 4 Magovcevic Ivana A - Award D 7,435
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)